Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the resignation of the company\'s deputy general manager
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement regarding the subsidiary's approval of the marketing authorization application for chemical raw material active pharmaceutical ingredient.
Announcement regarding subsidiary obtaining pharmaceutical supplementary application approval letter.
Announcement on the Progress of Planning Changes in Actual Controllership of Important Equity-Participating Companies
Legal Opinion on the 2024 Third Interim Shareholders Meeting of China Meheco Group Co., Ltd.
Announcement of the resolution of the third interim shareholders meeting in 2024.
Material for the third interim shareholder meeting in 2024.
Announcement regarding the controlling shareholder's proposed extension of the deadline for fulfilling commitments related to avoiding competition with the company's medical instrument sales business.
Announcement regarding subsidiary obtaining pharmaceutical supplementary application approval letter.
Notice on convening the third extraordinary shareholder meeting in 2024.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Legal Opinion on the 2024 Second Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd.
Announcement on the election of the chairman
2024 Second Extraordinary General Meeting of Shareholders Information
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion on the 2023 Annual General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd.
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
No Data
No Data